Resultats de la cerca - Ruei‐Min Lu

  • Mostrar 1 - 10 resultats de 10
Refinar resultats
  1. 1
    The WW Domain-Containing Proteins Interact with the Early Spliceosome and Participate in Pre-mRNA Splicing In Vivo

    The WW Domain-Containing Proteins Interact with the Early Spliceosome and Participate in Pre-mRNA Splicing In Vivo per Kai‐Ti Lin, Ruei‐Min Lu, Woan‐Yuh Tarn

    Publicat 2004
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Advancement and applications of peptide phage display technology in biomedical science

    Advancement and applications of peptide phage display technology in biomedical science per Chien‐Hsun Wu, I-Ju Liu, Ruei‐Min Lu, Han‐Chung Wu

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    The RNA Binding Protein hnRNP Q Modulates the Utilization of Exon 7 in the Survival Motor Neuron 2 (<i>SMN2</i>) Gene

    The RNA Binding Protein hnRNP Q Modulates the Utilization of Exon 7 in the Survival Motor Neuron 2 (<i>SMN2</i>) Gene per Hung-Hsi Chen, Jan-Growth Chang, Ruei‐Min Lu, Tsui-Yi Peng, Woan‐Yuh Tarn

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Epithelial Cell Adhesion Molecule Regulation Is Associated with the Maintenance of the Undifferentiated Phenotype of Human Embryonic Stem Cells

    Epithelial Cell Adhesion Molecule Regulation Is Associated with the Maintenance of the Undifferentiated Phenotype of Human Embryonic Stem Cells per Tung‐Ying Lu, Ruei‐Min Lu, Mei‐Ying Liao, John Yu, Chu-Hung Chung, Cheng-Fu Kao, Han‐Chung Wu

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Development of therapeutic antibodies for the treatment of diseases

    Development of therapeutic antibodies for the treatment of diseases per Ruei‐Min Lu, Yu‐Chyi Hwang, I-Ju Liu, Chi‐Chiu Lee, Han-Zen Tsai, Hsin‐Jung Li, Han‐Chung Wu

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  6. 6
    An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer

    An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer per Mei-Ying Liao, Jun-Kai Lai, Mark Yen‐Ping Kuo, Ruei-Min Lu, Cheng‐Wei Lin, Ping-Chang Cheng, Kang-Hao Liang, Han‐Chung Wu

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection

    Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection per Yu‐Chyi Hwang, Ruei‐Min Lu, Shih-Chieh Su, Pao-Yin Chiang, Shih-Han Ko, Feng-Yi Ke, Kang-Hao Liang, Tzung-Yang Hsieh, Han‐Chung Wu

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  8. 8
    Targeted Drug Delivery Systems Mediated by a Novel Peptide in Breast Cancer Therapy and Imaging

    Targeted Drug Delivery Systems Mediated by a Novel Peptide in Breast Cancer Therapy and Imaging per Ruei‐Min Lu, Minshan Chen, De-Kuan Chang, Chien‐Yu Chiu, Wei-Chuan Lin, Shin-Long Yan, Yi‐Ping Wang, Yuan‐Sung Kuo, Chen-Yun Yeh, Albert Lo, Han‐Chung Wu

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Current landscape of mRNA technologies and delivery systems for new modality therapeutics

    Current landscape of mRNA technologies and delivery systems for new modality therapeutics per Ruei‐Min Lu, Hsiang-En Hsu, Ser John Lynon P Perez, Monika Kumari, Guanhong Chen, Ming-Hsiang Hong, Yin-Shiou Lin, Ching-Hang Liu, Shih-Han Ko, Christian Angelo P. Concio, Yi‐Jen Su, Yi‐Han Chang, Wen‐Shan Li, Han‐Chung Wu

    Publicat 2024
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  10. 10
    A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies

    A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies per Monika Kumari, Ruei‐Min Lu, Mu‐Chun Li, Jhih‐Liang Huang, Fu‐Fei Hsu, Shih-Han Ko, Feng-Yi Ke, Shih-Chieh Su, Kang-Hao Liang, Joyce Pei-Yi Yuan, Hsiao-Ling Chiang, Cheng‐Pu Sun, I.-Jung Lee, Wen‐Shan Li, Hsing‐Pang Hsieh, Mi‐Hua Tao, Han‐Chung Wu

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:

Eines de cerca: